Charles River Laboratories International, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 6 | $2.06 | $2.06 | $2.06 |
| Q2 2024 | 3 | $2.39 | $2.39 | $2.39 |
| Q3 2024 | 4 | $2.42 | $2.42 | $2.42 |
| Q4 2024 | 11 | $2.46 | $2.63 | $2.54 |
| Q1 2025 | 8 | $2.28 | $2.60 | $2.38 |
| Q2 2025 | 4 | $2.46 | $2.59 | $2.52 |
| Q3 2025 | 7 | $2.59 | $2.72 | $2.66 |
| Q4 2025 | 4 | $2.76 | $2.90 | $2.83 |
| Q1 2026 | 6 | $2.53 | $2.66 | $2.59 |
| Q2 2026 | 3 | $2.73 | $2.86 | $2.79 |
| Q3 2026 | 6 | $2.84 | $2.99 | $2.91 |
| Q4 2026 | 3 | $3.02 | $3.17 | $3.09 |
| Q1 2027 | 6 | $2.63 | $2.76 | $2.69 |
| Q2 2027 | 3 | $2.58 | $2.71 | $2.65 |
| Q3 2027 | 6 | $3.14 | $3.29 | $3.21 |
| Q4 2027 | 3 | $3.50 | $3.68 | $3.59 |
Charles River Laboratories International, Inc. Earnings Date And Information
Charles River Laboratories International, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $2.59 earnings per share for the quarter, topping analysts' consensus estimates of $2.43 by $0.16. The company had revenue of 1.01 B for the quarter and had revenue of 4.13 B for the year. Charles River Laboratories International, Inc. has generated $9 earnings per share over the last year ($9.22 diluted earnings per share) and currently has a price-to-earnings ratio of 24.16. Charles River Laboratories International, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based on prior year's report dates.
Charles River Laboratories International, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2024 | Q3 2024 | $2.43 | $1.34 | -1.09 | $975.99 M | $1.01 B |
| 08/07/2024 | Q2 2024 | $2.39 | $1.75 | -0.64 | $1.03 B | |
| 05/09/2024 | Q1 2024 | $2.06 | $1.42 | -0.64 | $1.01 B | |
| 02/14/2024 | Q4 2023 | $2.39 | $3.65 | 1.26 | $1.01 B | |
| 11/08/2023 | Q3 2023 | $2.35 | $1.70 | -0.65 | $1.03 B | |
| 08/09/2023 | Q2 2023 | $2.63 | $1.89 | -0.74 | $1.06 B | |
| 05/11/2023 | Q1 2023 | $2.59 | $2.02 | -0.57 | $1.03 B | |
| 02/22/2023 | Q4 2022 | $2.75 | $3.68 | 0.93 | $1.10 B | |
| 11/02/2022 | Q3 2022 | $2.51 | $1.90 | -0.61 | $989.16 M | |
| 08/03/2022 | Q2 2022 | $2.73 | $2.15 | -0.58 | $973.13 M | |
| 05/04/2022 | Q1 2022 | $2.71 | $1.84 | -0.87 | $913.93 M | |
| 02/16/2022 | Q4 2021 | $2.43 | $2.73 | 0.3 | $905.05 M | |
| 11/03/2021 | Q3 2021 | $2.57 | $2.05 | -0.52 | $895.94 M | |
| 08/04/2021 | Q2 2021 | $2.39 | $1.76 | -0.63 | $914.61 M | |
| 05/04/2021 | Q1 2021 | $2.19 | $1.23 | -0.96 | $824.57 M | |
| 02/17/2021 | Q4 2020 | $2.11 | $2.88 | 0.77 | $790.99 M | |
| 11/09/2020 | Q3 2020 | $1.80 | $2.07 | 0.27 | $743.30 M | |
| 08/05/2020 | Q2 2020 | $1.26 | $1.36 | 0.1 | $682.58 M | |
| 05/07/2020 | Q1 2020 | $1.48 | $1.03 | -0.45 | $707.06 M | |
| 02/11/2020 | Q4 2019 | $1.83 | $1.64 | -0.19 | $691.14 M |
Charles River Laboratories International, Inc. Earnings: Frequently Asked Questions
-
When is Charles River Laboratories International, Inc.'s earnings date?
Charles River Laboratories International, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based off last year's report dates.
-
Did Charles River Laboratories International, Inc. beat their earnings estimates last quarter?
In the previous quarter, Charles River Laboratories International, Inc. (:CRL) reported $2.59 earnings per share (EPS) to beat the analysts' consensus estimate of $2.43 by $0.16.
-
How can I listen to Charles River Laboratories International, Inc.'s earnings conference call?
The conference call for Charles River Laboratories International, Inc.'s latest earnings report can be listened to online.
-
How can I read Charles River Laboratories International, Inc.'s conference call transcript?
The conference call transcript for Charles River Laboratories International, Inc.'s latest earnings report can be read online.
-
How much revenue does Charles River Laboratories International, Inc. generate each year?
Charles River Laboratories International, Inc. (:CRL) has a recorded annual revenue of $4.13 B.
-
How much profit does Charles River Laboratories International, Inc. generate each year?
Charles River Laboratories International, Inc. (:CRL) has a recorded net income of $4.13 B. Charles River Laboratories International, Inc. has generated $9.27 earnings per share over the last four quarters.
-
What is Charles River Laboratories International, Inc.'s price-to-earnings ratio?
Charles River Laboratories International, Inc. (:CRL) has a price-to-earnings ratio of 24.16 and price/earnings-to-growth ratio is -5.72.
